Gender Male
As Chief Medical Officer Dr. James Kyle Bryan is responsible for strategic global medical and scientific leadership for our company, leading the Medical, Safety, Feasibility, Oncology Strategy, and Global Strategic Delivery teams. Kyle draws on his knowledge of drug development and his clinical experience to advise and assist our customers.
Focused on drug discovery and development in the biotechnology and pharmaceutical industries for more than 25 years, Kyle offers a unique perspective on navigating medical and safety challenges and needs within clinical trials. He has worked in biotechnology companies as well as for clinical research organizations.
